Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Evaluating anti-viral effect of Tylvalosin tartrate on porcine reproductive and respiratory syndrome virus and analyzing the related gene regulation by transcriptomics

Fig. 2

Cellular toxicity of three kinds of commercial Tylvalosin tartrates to MARC-145 cells and primary PAMs. Tylvalosin tartrates with different concentrations (1, 10, 20, 40, 50 and 100 µg/mL) in DMEM or RPMI-1640 with 2% FBS were added to both MARC-145 cells and primary PAMs for 36 h incubation. The cellular toxicity was determined by testing the cell viabilities of MARC-145 cells (A) and primary PAMs (B) via CCK-8, compared with the untreated cells. The data are shown as means ± SD (standard deviation), n = 3 independent experiments. Asterisks indicate a statistically significant difference, compared with untreated cells (*p < 0.05; **p < 0.01; ***p < 0.001)

Back to article page

Virology Journal

ISSN: 1743-422X